Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jagadish Beloor

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2014
Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNAJagadish Beloor, Hye Yeong Nam, Sang-Kyung Lee, et al.
Methods in Enzymology|January 3, 2012
Cell-specific siRNA delivery by peptides and antibodiesSang-Kyung Lee, Alyssa Siefert, Jagadish Beloor, et al.
Human Gene Therapy|May 9, 2015
Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized MiceShan Liu, Andrew Jackson, Jagadish Beloor, et al.
Journal of Visualized Experiments : Jove|September 3, 2019
A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous SystemIrfan Ullah, Kunho Chung, Jagadish Beloor, et al.
Therapeutic Delivery|May 22, 2015
Cationic cell-penetrating peptides as vehicles for siRNA deliveryJagadish Beloor, Skye Zeller, Chang Seon Choi, et al.
Genome Research|April 4, 2014
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNASuresh Ramakrishna, Abu-Bonsrah Kwaku Dad, Jagadish Beloor, et al.
Cell Host & Microbe|April 3, 2018
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile VirusJagadish Beloor, Nyree Maes, Irfan Ullah, et al.
AIDS (London, England)|October 10, 2021
Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maravirocRonald Rose, Margaret Gartland, Zhufang Li, et al.
Molecular Pharmacology|February 8, 2017
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infectionShalley N Kudalkar, Jagadish Beloor, Albert H Chan, et al.
Antiviral Research|July 6, 2024
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumabMargaret Gartland, Eugene Stewart, Nannan Zhou, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2014
Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNAJagadish Beloor, Hye Yeong Nam, Sang-Kyung Lee, et al.
Methods in Enzymology|January 3, 2012
Cell-specific siRNA delivery by peptides and antibodiesSang-Kyung Lee, Alyssa Siefert, Jagadish Beloor, et al.
Human Gene Therapy|May 9, 2015
Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized MiceShan Liu, Andrew Jackson, Jagadish Beloor, et al.
Journal of Visualized Experiments : Jove|September 3, 2019
A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous SystemIrfan Ullah, Kunho Chung, Jagadish Beloor, et al.
Therapeutic Delivery|May 22, 2015
Cationic cell-penetrating peptides as vehicles for siRNA deliveryJagadish Beloor, Skye Zeller, Chang Seon Choi, et al.
Genome Research|April 4, 2014
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNASuresh Ramakrishna, Abu-Bonsrah Kwaku Dad, Jagadish Beloor, et al.
Cell Host & Microbe|April 3, 2018
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile VirusJagadish Beloor, Nyree Maes, Irfan Ullah, et al.
AIDS (London, England)|October 10, 2021
Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maravirocRonald Rose, Margaret Gartland, Zhufang Li, et al.
Molecular Pharmacology|February 8, 2017
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infectionShalley N Kudalkar, Jagadish Beloor, Albert H Chan, et al.
Antiviral Research|July 6, 2024
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumabMargaret Gartland, Eugene Stewart, Nannan Zhou, et al.
Pageof 3